Plug Power Investment
Headlands Technologies Acquires 1.76 Million Plug Power Shares in Q2
Anonymous
Key Points
1
Plug Power’s stock has a relatively high level of institutional ownership at about 43.48% of shares outstanding, per Headlands’ 13F filing context that also highlights other institutions’ activity.
2
Gilead Sciences now represents roughly 0.7% of Headlands Technologies’ portfolio and has recent headlines that could influence its outlook, including FDA approval of Bixlenvo and EU approval of Trodelvy plus Keytruda for certain breast cancer patients.
3
GE HealthCare Technologies saw a dramatic increase in Headlands’ stake in Q2, jumping 499.9% to 58,990 shares (about $3.78 million in value).
4
Mondelez International is among Headlands’ larger new positions, making up about 0.8% of the portfolio and ranking as the fund’s 20th largest holding.
5
The iShares Russell 2000 ETF (IWM) constituted another new position for Headlands in Q2, with 12,600 shares purchased; the ETF’s trading context at the time included an opening price of about $295.75 and a 12-month low near $228.90.
Headlands Technologies LLC bought 1.76 million shares of Plug Power in Q2, spending about $4.78 million on what marks a new position for the investment firm. Watchlist News reports the purchase gives Headlands roughly 0.13% of the hydrogen fuel cell company. The move comes as Headlands broadened its portfolio across healthcare, consumer goods, and small-cap equities during the quarter.
Beyond Plug Power, Headlands opened or expanded positions in five other securities worth nearly $26 million combined. The firm acquired 49,478 shares of Gilead Sciences, 12,600 shares of the iShares Russell 2000 ETF, 125,577 shares of Mondelez International, and boosted its GE HealthCare stake by nearly 500%.
Plug Power Adds Major Institutional Owner
Watchlist News confirmed that Headlands paid roughly $2.71 per share for its 1.76 million Plug Power stake. At the time of the purchase, this represented a notable institutional vote of confidence in the hydrogen energy company. Plug Power already carries roughly 43.48% institutional ownership across all shareholders, making it a popular holding among money managers seeking clean energy exposure.
Gilead Sciences Breaks Into Portfolio
Headlands opened a 49,478-share position in Gilead Sciences worth about $6.25 million, now representing roughly 0.7% of the firm's portfolio. Watchlist News notes the pharmaceutical company recently won FDA approval for its drug Bixlenvo. The European Union also green-lit Trodelvy combined with Keytruda for certain breast cancer patients, potentially bolstering Gilead's revenue outlook.
GE HealthCare Stake Jumps Nearly 500%
Headlands dramatically increased its GE HealthCare Technologies holding by purchasing 49,157 additional shares in Q2. Watchlist News reports the position grew 499.9% to reach 58,990 total shares valued at roughly $3.78 million. The aggressive expansion signals strong conviction in the medical imaging and diagnostics company's near-term prospects.
Diversification Into Consumer and Small-Cap Stocks
Headlands also bought 125,577 shares of Mondelez International for about $7.26 million, ranking it as the firm's 20th largest holding at roughly 0.8% of portfolio weight. Watchlist News reports the snack food maker attracted the institutional investor's attention. Additionally, Headlands purchased 12,600 shares of the iShares Russell 2000 ETF at prices near $295.75, giving the firm small-cap U.S. stock exposure.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
29
Articles
16
Reach
45
A
AnonymousAuthor
